These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31341191)

  • 21. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa.
    Tanser F; Bärnighausen T; Grapsa E; Zaidi J; Newell ML
    Science; 2013 Feb; 339(6122):966-71. PubMed ID: 23430656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spatial clustering of "measured" and "unmeasured" risk factors for HIV infections in hyper-endemic communities in KwaZulu-Natal, South Africa: results from geoadditive models.
    Wand H; Ramjee G
    AIDS Care; 2015; 27(11):1375-81. PubMed ID: 26679265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction in extrapulmonary tuberculosis in context of antiretroviral therapy scale-up in rural South Africa.
    Hoogendoorn JC; Ranoto L; Muditambi N; Railton J; Maswanganyi M; Struthers HE; McIntyre JA; Peters RPH
    Epidemiol Infect; 2017 Sep; 145(12):2500-2509. PubMed ID: 28748775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spatial clustering of drug-resistant tuberculosis in Hlabisa subdistrict, KwaZulu-Natal, 2011-2015.
    Smith CM; Lessells R; Grant AD; Herbst K; Tanser F
    Int J Tuberc Lung Dis; 2018 Mar; 22(3):287-293. PubMed ID: 29471906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The scale-up of antiretroviral therapy coverage was strongly associated with the declining tuberculosis morbidity in Africa during 2000-2018.
    Boah M; Jin B; Adampah T; Wang W; Wang K
    Public Health; 2021 Feb; 191():48-54. PubMed ID: 33508661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution of advanced HIV disease from three high HIV prevalence settings in Sub-Saharan Africa: a secondary analysis data from three population-based cross-sectional surveys in Eshowe (South Africa), Ndhiwa (Kenya) and Chiradzulu (Malawi).
    Chihana ML; Huerga H; Van Cutsem G; Ellman T; Goemaere E; Wanjala S; Masiku C; Szumilin E; Etard JF; Maman D; Davies MA
    Glob Health Action; 2019; 12(1):1679472. PubMed ID: 31679482
    [No Abstract]   [Full Text] [Related]  

  • 27. Incidence of tuberculosis and the need of prophylactic treatment in persons living with HIV in Stockholm during the era of anti-retroviral therapy 1996-2013.
    Norrby M; Wannheden C; Ekström AM; Berggren I; Lindquist L
    Infect Dis (Lond); 2018; 50(11-12):807-816. PubMed ID: 30362392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiretroviral therapy and TB notification rates in a high HIV prevalence South African community.
    Middelkoop K; Bekker LG; Myer L; Johnson LF; Kloos M; Morrow C; Wood R
    J Acquir Immune Defic Syndr; 2011 Mar; 56(3):263-9. PubMed ID: 21317585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors influencing treatment default among tuberculosis patients in a high burden province of South Africa.
    Kigozi G; Heunis C; Chikobvu P; Botha S; van Rensburg D
    Int J Infect Dis; 2017 Jan; 54():95-102. PubMed ID: 27894985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying 'corridors of HIV transmission' in a severely affected rural South African population: a case for a shift toward targeted prevention strategies.
    Tanser F; Bärnighausen T; Dobra A; Sartorius B
    Int J Epidemiol; 2018 Apr; 47(2):537-549. PubMed ID: 29300904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment outcomes among children, adolescents, and adults on treatment for tuberculosis in two metropolitan municipalities in Gauteng Province, South Africa.
    Berry KM; Rodriguez CA; Berhanu RH; Ismail N; Mvusi L; Long L; Evans D
    BMC Public Health; 2019 Jul; 19(1):973. PubMed ID: 31331311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do self-assessments of health predict future mortality in rural South Africa? The case of KwaZulu-Natal in the era of antiretroviral treatment.
    Olgiati A; Bärnighausen T; Newell ML
    Trop Med Int Health; 2012 Jul; 17(7):844-53. PubMed ID: 22780556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiretroviral Therapy to Prevent HIV Acquisition in Serodiscordant Couples in a Hyperendemic Community in Rural South Africa.
    Oldenburg CE; Bärnighausen T; Tanser F; Iwuji CC; De Gruttola V; Seage GR; Mimiaga MJ; Mayer KH; Pillay D; Harling G
    Clin Infect Dis; 2016 Aug; 63(4):548-54. PubMed ID: 27208044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Timing of HIV diagnosis in children with tuberculosis managed at a referral hospital in Cape Town, South Africa.
    Byamungu LN; du Preez K; Walters E; Nachega JB; Schaaf HS
    Int J Tuberc Lung Dis; 2018 May; 22(5):488-495. PubMed ID: 29663952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wide Variations in Compliance with Tuberculosis Screening Guidelines and Tuberculosis Incidence between Antiretroviral Therapy Facilities - Côte d'Ivoire.
    Auld AF; Blain M; Ekra KA; Kouakou JS; Ettiègne-Traoré V; Tuho MZ; Mohamed F; Shiraishi RW; Sabatier J; Essombo J; Adjorlolo-Johnson G; Marlink R; Ellerbrock TV
    PLoS One; 2016; 11(6):e0157059. PubMed ID: 27275742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increasing HIV prevalence in a rural district of South Africa from 1992 through 1995.
    Coleman RL; Wilkinson D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Sep; 16(1):50-3. PubMed ID: 9377125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A clinical algorithm for same-day HIV treatment initiation in settings with high TB symptom prevalence in South Africa: The SLATE II individually randomized clinical trial.
    Maskew M; Brennan AT; Fox MP; Vezi L; Venter WDF; Ehrenkranz P; Rosen S
    PLoS Med; 2020 Aug; 17(8):e1003226. PubMed ID: 32853271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of engaging unpaid informal providers on case detection and treatment initiation rates for TB and HIV in rural Malawi (Triage Plus): A cluster randomised health system intervention trial.
    Bello G; Faragher B; Sanudi L; Namakhoma I; Banda H; Malmborg R; Thomson R; Squire SB
    PLoS One; 2017; 12(9):e0183312. PubMed ID: 28877245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Barriers to antiretroviral treatment initiation in rural KwaZulu-Natal, South Africa.
    Plazy M; Newell ML; Orne-Gliemann J; Naidu K; Dabis F; Dray-Spira R
    HIV Med; 2015 Oct; 16(9):521-32. PubMed ID: 25857535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Finding patients eligible for antiretroviral therapy using TB services as entry point for HIV treatment.
    Bwire R; Nagelkerke NJ; Borgdorff MW
    Trop Med Int Health; 2006 Oct; 11(10):1567-75. PubMed ID: 17002731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.